HCW Biologics

HCW Biologics is an innovative immunotherapy company developing new treatments aimed at disrupting the link between chronic, low-grade inflammation and age-related diseases. This field is known as inflammaging, targeting unresolved inflammatory responses and chronic low-grade inflammation associated with aging, which are considered significant contributing factors to cancer and various chronic conditions, including cardiovascular disease, diabetes, neurodegenerative diseases, and autoimmune disorders. We believe our approach has the potential to offer an innovative treatment for these age-related diseases.